A Study Of Efficacy And Safety With Apatinib Or Apatinib Combined With Chemotherapy In Recurrent/advanced Ovarian Cancer Patients

OBJECTIVES: Despite recent advances in the treatment of advanced ovarian cancer, drug selection after second-line chemotherapy has not been well studied. In this study, we retrospectively evaluated the effect and safety of apatinib as monotherapy or in combination with chemotherapy for the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Mi, Liu, Xiufeng, Zhang, Cheng, Liao, Feng, Li, Zixiong, Luo, Xianwen, Sun, Yiran, Chen, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790407/
https://www.ncbi.nlm.nih.gov/pubmed/31632146
http://dx.doi.org/10.2147/CMAR.S223372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790407/
https://www.ncbi.nlm.nih.gov/pubmed/31632146
http://dx.doi.org/10.2147/CMAR.S223372

Ejemplares similares